Delivery Order SPE2DB22D1017-SPE2DB25FYPSM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) valued at $1,066.56. This non-set-aside competitive award reflects a firm fixed-price delivery order with an ultimate completion date of August 29, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count units) with a ceiling value of $1,066.56. This non-set-aside, firm fixed-price delivery order is set for ultimate completion on August 21, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a contract value of $1,660.95. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under...
- The Defense Logistics Agency awarded a $1,111.00 delivery order to AmerisourceBergen Drug Corp for Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count unit) with a ceiling value of $10,115.22. This competitively awarded, non-set-aside contract employs firm fixed-price terms and has an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work...
- The Defense Logistics Agency awarded a delivery order valued at $2,533.09 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) on August 7, 2025, with completion targeted for August 8, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 40 mg capsules (30-count) with a ceiling value of $2,133.12. This competitive contract, awarded on August 20, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Esomeprazole Magnesium Delayed Release 40 mg capsules (30-count) at a firm fixed price of $1,928.75, with an ultimate completion date of August 20, 2025. This is a non-set-aside, competitively awarded contract, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 40 mg capsules (30-count) on July 23, 2025, with a ceiling value of $1,713.18 and completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered...
- The Defense Logistics Agency awarded a delivery order valued at $2,133.12 to AmerisourceBergen Drug Corp for Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count supply) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed price, competitively awarded delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen Drug...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYPSMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,619.57 to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count packaging), with final delivery due by September 3, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies pharmaceutical products and medical commodities to military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC functions as a comprehensive global pharmaceutical support vehicle, enabling the company to supply an extensive range of generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The delivery order structure demonstrates DLA's utilization of this large-value contract vehicle to efficiently procure specific pharmaceutical commodities on an as-needed basis for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 9/2/25 |